Related Experiment Video
Updated: Mar 17, 2026
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Circulating microparticles as a predictor of vascular properties in patients on mechanical circulatory support; hype
1Institute for Clinical and Experimental Medicine, Prague, Czech Republic. peter.ivak@ikem.cz.
Abstract:
Microparticles are small circulating vesicles originating from circulatory system and vascular wall cells released during their activation or damage. They possess different roles in regulation of endothelial function, inflammation, thrombosis, angiogenesis, and in general, cellular stress. Microparticles are the subject of intensive research in pulmonary hypertension, atherosclerotic disease, and heart failure. Another recently emerging role is the evaluation of the status of vasculature in end-stage heart failure patients treated with implantable ventricular assist devices. In patients implanted as destination therapy, assessment of the long-term effect of currently used continuous-flow left ventricular assist devices (LVADs) on vasculature might be of critical importance. However, unique continuous flow pattern generated by LVADs makes it difficult to assess reliably the vascular function with most currently used methods, based mainly on ultrasound detection of changes of arterial dilatation during pulsatile flow. In this respect, the measurement of circulating microparticles as a marker of vascular status may help to elucidate both short- and long-term effects of LVADs on the vascular system. Because data regarding this topic are very limited, this review is focused on the advantages and caveats of the circulating microparticles as markers of vascular function in patients on continuous-flow LVADs.
Insights
Circulating microparticles offer a novel way to assess vascular health in patients with continuous-flow left ventricular assist devices (LVADs). This review explores their potential to track LVAD effects on vasculature, overcoming limitations of traditional methods.
Area of Science:
- Cardiovascular Research
- Biomedical Engineering
- Vascular Biology
Background:
- Microparticles are vesicles released from activated or damaged cells, involved in vascular regulation and cellular stress.
- They are studied in pulmonary hypertension, atherosclerotic disease, and heart failure.
- Assessing vascular status in heart failure patients with continuous-flow left ventricular assist devices (LVADs) is crucial.
Purpose of the Study:
- To review the advantages and limitations of using circulating microparticles to evaluate vascular function in patients with continuous-flow LVADs.
- To address the limited data on microparticles in the context of LVAD therapy.
- To highlight microparticles as potential biomarkers for LVAD-induced vascular changes.
Main Methods:
- Literature review focusing on circulating microparticles and LVADs.
- Analysis of current methods for assessing vascular function in LVAD patients.
- Discussion of microparticle detection and interpretation in this specific population.
Main Results:
- Traditional vascular assessment methods are challenged by the continuous flow generated by LVADs.
- Circulating microparticles may provide a reliable indicator of vascular status despite altered flow dynamics.
- Data on microparticles in LVAD patients are currently scarce, necessitating further research.
Conclusions:
- Circulating microparticles show promise as biomarkers for monitoring vascular health in LVAD recipients.
- They may offer insights into both short- and long-term vascular effects of continuous-flow LVADs.
- Further investigation is warranted to establish the clinical utility of microparticles in this patient group.
